Tüdőrák: vizsgálatok itt: Franciaország
318 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisNot yet taking people in FranciaországA Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
- Where
- Bordeaux, Lyon, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06476808 · EU 2025-523067-38-01 - 3. fázisVisszavonvaA Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy
- Where
- Angers, Bordeaux, Créteil, Grenoble Cedex 9, Lyon, Montpellier, Pessac, Rouen Cedex, Saint-Herblain Cedex, Tours Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 147 worldwide
- Run by
- Shanghai Junshi Biosciences Co. Ltd.
See details and how to join2023-507097-41-01 - 2. fázisTaking peopleStudy of pre- and post-surgery treatment with IPH5201 and durvalumab in participants with lung cancer (MATISSE)
- Where
- Lille, Limoges Cedex 1, Lyon, Marseille, Rennes, Villejuif
- Életkor
- 18 év to 64 év
- People
- 69 worldwide
- Run by
- Innate Pharma
See details and how to join2023-507778-42-00 - No phaseTaking peoplePilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
- Where
- Dijon
- Életkor
- 18 év and over
- People
- 56
- Run by
- Centre Hospitalier Universitaire Dijon
See details and how to joinNCT05985330 - 1/2. fázisTaking peopleClinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.
- Where
- Dijon
- Életkor
- 18 év and over
- People
- 24
- Run by
- Centre Georges Francois Leclerc
See details and how to joinNCT05937906 - No phaseTaking peoplePerformance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules
- Where
- Pessac
- Életkor
- 55 év to 74 év
- People
- 50
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT06825078 - 1/2. fázisNot yet taking people in FranciaországA Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Where
- Marseille, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 262 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07174583 · EU 2025-523438-24-00 - 2. fázisTaking peoplePhase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
- Where
- Aix En Provence, Angers, Brest, Bron, Caen Cedex 5, Chambéry, Colmar Cedex, Creteil Cedex, La Roche Sur Yon Cedex 9, Lille, Limoges Cedex 1, Marseille, Pessac, Quimper Cedex, Rennes, Rouen Cedex, Suresnes, Toulon Cedex 9, Toulouse, Villefranche Sur Saone Cedex
- Életkor
- 18 év and over
- People
- 30
- Run by
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
See details and how to joinNCT06552234 · EU 2023-509073-23-00 - 1. fázisTaking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Angers, Nice Cedex 2, Poitiers, Vandouvre Les Nancy, Villejuif
- Életkor
- 18 év and over
- People
- 1006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - 1/2. fázisTaking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Dijon, Marseille, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - 1/2. fázisTaking peoplePHASE IB/II CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICACY OF CHEMOIMMUNOTHERAPY PLUS SHORT COURSE OF MEK INHIBITOR IN FIRST LINE OF TREATMENT OF METASTATIC NON SQUAMOUS NON SMALL CELL LUNG ADENOCARCINOMA WITH PDL1 <50%
- Where
- Dijon
- Életkor
- 18 év and over
- People
- 102
- Run by
- Centr Georges Francois Leclerc
See details and how to join2023-508477-87-00 - 2. fázisTaking peopleSingle Arm Study of WSD0922-FU for NSCLC Patients with C797S mutation
- Where
- Caen Cedex 5, Limoges, Pessac, Rennes Cedex 9, Toulon Cedex
- Életkor
- 18 év and over
- People
- 10
- Run by
- Wayshine Biopharm Inc.
See details and how to join2024-519713-65-00 - 2. fázisTaking peopleAutologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Where
- Amiens Cedex 1, Clermont-Ferrand, Marseille, Nancy Cedex, Nice, Pierre-Bénite, Poitiers, Saint-Herblain, Villejuif
- Életkor
- 18 év to 70 év
- People
- 170 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT04614103 · EU 2024-510778-26-00 - Korai 1. fázisNot yet taking people in FranciaországEvaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)
- Where
- Angers, Saint-Herblain Cedex
- Életkor
- 18 év and over
- People
- 15
- Run by
- Institut Cancerologie de l'Ouest
See details and how to joinNCT07007325 · EU 2024-514057-30-00 - 2. fázisTaking peopleIPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
- Where
- Angers, Caen, Lille, Limoges, Lyon, Marseille, Rennes, Rouen, Villejuif
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Innate Pharma
See details and how to joinNCT05742607 - No phaseTaking peopleImpact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase
- Where
- Brest, Morlaix, Quimper
- Életkor
- 18 év and over
- People
- 96
- Run by
- University Hospital, Brest
See details and how to joinNCT06441773 - 2. fázisTaking peopleA randomized multicenter Phase II trial evaluating oral pooled fecal microbiotherapy (MaaT033) concomitant to Cemiplimab (CB) versus best investigator’s choice (BIC) in resistance to PD-1/PD-L1 blockade due to antibiotics (ATB) uptake in patients with advanced non-small cell lung cancer (NSCLC) - IMMUNOLIFE2
- Where
- Aix En Provence, Beuvry, Bordeaux, Dijon, Grenoble Cedex 9, Marseille, Nice Cedex 2, Paris, PARIS, Paris Cedex 18, Suresnes, Toulon, Villejuif
- Életkor
- 18 év to 64 év
- People
- 162
- Run by
- Institut Gustave Roussy
See details and how to join2024-517018-14-00 - No phaseTaking peopleHybrid Prehabilitation Before Thoracic Surgery
- Where
- Rouen
- Életkor
- 18 év and over
- People
- 38
- Run by
- ADIR Association
See details and how to joinNCT06866717 - No phaseTaking peopleImplementing Low-dose ct Lung Cancer Screening in France.
- Where
- Lyon, Paris
- Életkor
- 50 év to 74 év
- People
- 20 000
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07513818 - 1/2. fázisBefejeződöttA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Bayonne, Caen Cedex 5, Lille, Lyon, Marseille, Nice Cedex 2, Paris, St Herblain, Strasbourg, Villejuif
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00 - 1. fázisTaking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Marseille, Nice, Suresnes, Toulouse
- Életkor
- 18 év and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - 1/2. fázisTaking peopleDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
- Where
- Lyon, Montpellier Cedex 5, Paris, Rennes Cedex, Saint-Herblain Cedex, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 41 worldwide
- Run by
- OSE Immunotherapeutics
See details and how to joinNCT05751798 · EU 2024-514826-22-00 - 2. fázisNot yet taking people in FranciaországPhase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
- Where
- Clermont-Ferrand, Lyon, Nice Cedex 2, Reims, Villejuif
- Életkor
- 18 év and over
- People
- 158 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT07234877 · EU 2025-522985-60-00 - 1/2. fázisNot yet taking people in FranciaországA clinical trial to learn more about the effects of DJI136 in people with extensive-stage small cell lung cancer
- Where
- Lille, Marseille, Pierre-Bénite
- Életkor
- 18 év and over
- People
- 25 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-523276-23-00 - 2. fázisTaking peopleNiraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
- Where
- Angers, Avignon, Caen Cedex 9, Lyon
- Életkor
- 18 év and over
- People
- 44 worldwide
- Run by
- ETOP IBCSG Partners Foundation
See details and how to joinNCT05718323 · EU 2022-502092-33-00